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Abstract
Background: Bovine Leukemia virus (BLV) is a deltaretrovirus that induces lymphoproliferation
and leukemia in ruminants. In ex vivo cultures of B lymphocytes isolated from BLV-infected sheep
show that spontaneous apoptosis is reduced. Here, we investigated the involvement of reactive
oxygen species (ROS) in this process.
Results: We demonstrate that (i) the levels of ROS and a major product of oxidative stress (8-
OHdG) are reduced, while the thioredoxin antioxidant protein is highly expressed in BLV-infected
B lymphocytes, (ii) induction of ROS by valproate (VPA) is pro-apoptotic, (iii) inversely, the
scavenging of ROS with N-acetylcysteine inhibits apoptosis, and finally (iv) the levels of ROS
inversely correlate with the proviral loads.
Conclusion: Together, these observations underline the importance of ROS in the mechanisms
of inhibition of apoptosis linked to BLV infection.
Background
Bovine Leukemia Virus (BLV) is an oncogenic deltaretro-
virus closely related to the primate T-lymphotropic viruses
types 1-5 (i.e. HTLV-1 to -4 and STLV-1,-2,-3 and-5) [1-3].
Although successfully eradicated in some regions such as
Europe, BLV is distributed worldwide. Infection remains
mostly clinically silent with infected animals being
referred to as asymptomatic or non-leukemic (AL) [4].
Only one-third of infected cattle develop a persistent lym-
phocytosis (PL) characterized by a permanent and rela-
tively stable increase in the number of peripheral blood B
lymphocytes co-expressing CD5, high levels of surface
immunoglobulin M (sIgM), and myeloid markers [5,6].
The natural host for BLV is cattle which develops a fatal
leukemia or a lymphoma in fewer than 5% of infected
animals and after a long latency period (4-8 years) [7].
BLV can be transmitted experimentally to sheep which
develop B-cell neoplasia with a higher incidence and after
shorter latency periods than cattle [8]. This model may be
helpful for understanding pathogenesis induced by the
related human T-lymphotropic virus type I (HTLV-1).
We previously reported that the disruption of lymphocyte
homeostasis results from a disequilibrium between cell
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proliferation and death [9,10]. Using BrdU (bromodeox-
yuridine) and CFSE (carboxyfluorescein diacetate succin-
imidyl ester) labeling techniques, we showed that the
dynamics of lymphocyte recirculation is unaltered but
that the cell turnover is accelerated. Although these kinetic
experiments are useful to explain the accumulation of
infected cells in vivo, further understanding of BLV-
induced pathogenesis requires dissection of metabolic
pathways in vitro.
In this context, we have demonstrated that conditioned
supernatants from BLV-infected peripheral blood mono-
nuclear cell (PBMC) cultures can prevent uninfected cells
from undergoing apoptosis. This so-called "indirect" pro-
tection against apoptosis involves glutathione [11] which
is expected to buffer reactive oxygen species (ROS). On
the other hand, when PBMCs isolated from infected sheep
are transiently cultivated ex vivo, B-lymphocyte apoptosis
is decreased compared to matched uninfected controls.
This latter mechanism was referred to as "direct" protec-
tion against apoptosis [12,13]. In this work, we hypothe-
sized that ROS might be important mediators of this
process.
ROS are indeed implicated in the regulation of several cel-
lular processes depending on their intracellular levels. A
beneficial effect of ROS occurs in living cells at low/mod-
erate concentrations and is associated with important
physiological functions, including activation and modu-
lation of signal transduction pathways, defense against
infectious agents, induction of mitogenic response and
regulation of mitochondrial apoptotic process [14,15]. In
contrast, excessive levels of ROS are toxic to the cells caus-
ing damage to macromolecules such as lipids, proteins
and nucleic acids [16,17]. Thus, oxidative stress results
from an imbalance between ROS production and anti-oxi-
dant activity conferred by enzymes like thioredoxin, glu-
tathione peroxidase or glutathione reductase [18].
Alteration of the anti-oxidant system has been implicated
both in malignant phenotypes as well as in carcinogenesis
(see [19] for a review). For example, cancer cells are char-
acterized by a more reducing environment and overex-
pression of the anti-apoptotic Bcl-2 factor which enhances
resistance against ROS-induced-apoptosis [18].
Here, we evaluated the involvement of ROS in ex vivo
apoptosis associated with BLV infection.
Results
The ROS levels are reduced in B cells from BLV-infected 
sheep
We and others previously reported that the percentages of
B cells undergoing apoptosis in short term cultures are
reduced in BLV-infected sheep [12,13]. We confirmed this
observation in ex vivo cultures of peripheral blood mono-
nuclear cells (PBMCs) isolated from a series of sheep (13
BLV-positive and 6 controls) whose hematological pro-
files are provided in Additional file 1. Fig. 1A indeed
shows that the percentages of apoptotic B cells in PBMC
cultures isolated from BLV-infected sheep are reduced
compared to the controls (28.59% versus 39.96% respec-
tively; p < 0.01). In contrast, the levels of spontaneous
apoptosis were not significantly different (p = 0.19) in the
non-B cell populations. These results thus confirm and
extend previous reports in the literature [12,13]. Although
the sub-G1 cells resulting from DNA fragmentation are
the most specific hallmark of apoptosis, we confirmed
these conclusions by Annexin V labeling experiments
(data not shown).
We next measured the levels of intracellular reactive oxy-
gen species (ROS) using the 2'-7'-dichlorofluorescein dia-
cetate (CM-H2DCFDA) probe. The kinetics of ROS
production after short term cultures (30 mn, 3 h and 6 h)
were not significantly different in infected and control B
cells (Additional file 2). After 24 h of culture, ROS-stimu-
lated oxidation into 2'-7'-dichlorofluorescein was signifi-
cantly lower (p < 0.001) in B cells isolated from BLV-
infected PBMCs compared to controls (Fig. 1B). In con-
trast, ROS levels in non-B cells derived from BLV-infected
and control cultures were not significantly different (p =
0.1, Fig. 1B). Importantly, reduction in B cell apoptosis
correlates with decreased ROS production, the highest lev-
els being observed in control cells (Fig. 1C, R2 = 0.4097
and p < 0.05).
Reduced ROS production in mitochondria of BLV-infected 
B lymphocytes
Although the CM-H2DCFDA probe is routinely used to
assess ROS production in all cell compartments, we con-
firmed our results using the fixable probe, MitoTracker
Red CM-XROS, which specifically quantifies ROS levels
directly within mitochondria. Upon oxidation, red fluo-
rescence revealed by confocal microscopy was reduced in
B lymphocytes isolated from BLV-infected sheep and cul-
tivated for 24 h (compare arrows in fluorescence intensity
profiles of one representative experiment shown in Fig.
2A). Quantification in 20 randomly selected B cells from
3 BLV- infected and 3 control sheep demonstrated that the
means of fluorescence intensities in mitochondria of BLV-
infected B lymphocytes were indeed significantly lower
than in controls (Fig. 2B, p < 0.001).
These observations thus confirm that, upon cultivation, B
cells isolated from BLV-infected sheep produce lower lev-
els of ROS compared to uninfected controls.Retrovirology 2009, 6:102 http://www.retrovirology.com/content/6/1/102
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DNA oxidative damage is reduced in B lymphocytes of 
BLV-infected sheep
ROS species may cause a series of alterations to cell com-
ponents such as DNA, proteins or lipids. Oxidative DNA
damage can be measured by using the 8-hydroxy-2'-deox-
yguanosine (8-OHdG) product [20]. Therefore, we deter-
mined the percentages of 8-OHdG positive B cells in
PBMC cultures isolated from 3 BLV-infected and 3 control
sheep (Fig. 3). Flow cytometry analysis revealed that B-
lymphocytes staining for 8-OHdG were significantly
lower in BLV-infected cultures compared to controls (Fig.
3, p < 0.001). These results demonstrate that a major
product of oxidative DNA (8-OHdG) is reduced in B cells
isolated from BLV-infected sheep, providing a biological
relevance to ROS activity.
BLV-infected B cells express high levels of thioredoxin
We next analyzed the levels of the thioredoxin (TRX) anti-
oxidant protein. Western blot analysis of Fig. 4A show
that, compared to controls, thioredoxin was overex-
pressed in PBMCs isolated from BLV-infected sheep. Con-
sistently, thioredoxin fluorescence intensities measured
by flow cytometry were significantly higher in BLV-
infected B cells (Fig. 4B, p < 0.01). In contrast, thioredoxin
levels were not significantly different in non-B cell popu-
lations (Fig. 4B, p = 0.47).
These results demonstrate that B cells isolated from BLV-
infected sheep express high levels of thioredoxin.
Valproate (VPA)-induced apoptosis of BLV-infected B 
lymphocytes involves a ROS-dependent pathway
We previously reported an approach to treat leukemia in
BLV-infected sheep using the VPA histone deacetylase
inhibitor [21]. Since we showed that VPA acts at least in
part through induction of apoptosis, we investigated the
involvement of ROS in VPA therapy. As control, we first
analyzed histone H3 acetylation in presence of a thera-
peutic dose of 1 mM VPA as previously described [22]. As
expected for an HDAC inhibitor, VPA induced the hyper-
acetylation of histone H3 (Ac H3) (Fig. 5A). At the con-
centration of 1 mM, VPA was also proapoptotic for B
lymphocytes isolated from controls and BLV-infected
sheep (Fig. 5B), confirming our previous results [21]. To
determine the effect of VPA on ROS production, PBMCs
from BLV-infected (n = 6) and control sheep (n = 6) were
preincubated for 30 min at 37°C with 10 μM of CM-
H2DCFDA and then cultivated for 24 h with 1 mM of VPA.
Cell cultures undergoing increased apoptosis upon VPA
treatment also yielded increased ROS production (Fig.
5C). We concluded that VPA-induced apoptosis parallels
ROS production.
To correlate VPA-induced apoptosis in B lymphocytes and
reactive oxygen species, ROS production was inhibited
Figure 1 
Spontaneous apoptosis and ROS production in short
term cultures. A) Peripheral blood mononuclear cells
(PBMCs) from BLV-infected (n = 13) and control (n = 6)
sheep were isolated and cultivated for 24 h. B cells were
labeled using anti-IgM monoclonal antibody (clone 1H4) and
FITC-conjugated rabbit anti-mouse and fixed in ethanol.
After staining with PI, hypodiploid cells (sub-G1 population)
considered to be apoptotic were quantified by flow cytome-
try. Data are presented as the means of apoptotic rates ±
standard deviation. ** denotes the statistical significance
according to the non-paired Student's t test p < 0.01. B)
PBMCs from BLV-infected (n = 13) and non-infected sheep
(n = 6) were seeded in 24-well plates at a density of 106
cells/ml and incubated for 30 min at 37°C with 10 μM of CM-
H2DCFDA. After 24 h of culture, B cells were stained using
anti-IgM monoclonal (clone Pig45) and Alexa Fluor 647-con-
jugated donkey anti-mouse antibodies. The intracellular ROS
levels were determined by flow cytometry and are presented
as the mean fluorescence intensities (± standard deviation) of
cellular chloromethyldichlorofluorescein (CM-DCF) within B
and non-B lymphocyte populations. *** denotes the statisti-
cal significance according to the non paired Student's t test p
< 0.001. C) Correlation between apoptotic rates and ROS
levels measured in ex vivo cultures. Apoptotic rates and ROS
levels were determined by flow cytometry as described in
panels A and B, respectively. A correlation coefficient R2 =
0.4097 was calculated from the linear regression analysis on
percentages of apoptotic B cells and means of ROS fluores-
cence intensities. p < 0.05 denotes the statistical significance
according to the non parametric Spearman test.on next
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with 10 mM of the free radical scavenger N-acetyl cysteine
(NAC). As expected, NAC treatment resulted in a signifi-
cant inhibition of ROS in the presence of VPA in B cells
isolated from BLV-infected (Fig. 5D, p < 0.01) and control
sheep (Fig. 5D, p < 0.01). Concomitantly, NAC also effi-
ciently inhibited apoptosis of B lymphocytes isolated
from BLV-infected (Fig. 5E, p < 0.001) and control sheep
(Fig. 5E, p < 0.01). Collectively, these results show that
VPA-induced apoptosis in BLV-infected and control B
lymphocytes involves a ROS dependent pathway.
ROS levels correlate inversely with proviral load
Finally, we measured the proviral loads in PBMCs isolated
from 13 BLV-infected sheep using real-time PCR as
described previously [23]. In parallel, the intracellular
ROS levels were monitored upon cultivation of the same
samples using the CM-H2DCFDA probe. As shown in Fig.
6, ROS levels in B lymphocytes inversely correlated with
the proviral loads (correlation coefficient R2 = 0.7764 and
p < 0.001). These results show that spontaneous ROS pro-
duction is reduced in B cells from animals with high pro-
viral loads.
Discussion
We and others previously reported that extent of apopto-
sis is reduced in ex vivo cultures [12,13], suggesting that
the lifespan of BLV-infected B cells may also be prolonged
in vivo. However, the mechanisms involved are insuffi-
ciently understood. In this study, we provide new evi-
dence demonstrating that ROS play a key role in
inhibition of apoptosis associated with BLV infection.
Decreased levels of ROS as evidenced by two different flu-
orescent probes were detected in B cells isolated from
BLV-infected sheep. A direct marker of ROS-induced DNA
damage, 8-OHdG was also reduced, while thioredoxin
was overexpressed, further validating the antioxidant sta-
tus observed in BLV-infected B cells. We also showed that
VPA treatment increases ROS levels and concomitantly
induces apoptosis. Inversely, the scavenging of ROS with
NAC decreased apoptotic rates. Finally, spontaneous ROS
production inversely correlates with proviral loads meas-
ured in vivo.
Generation of ROS in B lymphocyte mitochondria Figure 2
Generation of ROS in B lymphocyte mitochondria. 
Confocal microscopy analysis of ROS production in B cells 
isolated from 3 BLV-infected and 3 control sheep. 24 h after 
culture, PBMCs were labeled with 10 nM of Red CM-XROS 
probe and stained with anti-IgM monoclonal antibody (clone 
Pig45) and Alexa Fluor 488 goat anti-mouse conjugate. A) 
Confocal microscopy photographs and profiles of one repre-
sentative experiment showing the fluorescence intensities of 
ROS (red fluorescence) and IgM (green fluorescence). For 
comparison, arrows indicate ROS levels (red) in B cells 
(green) in PBMCs from infected and control sheep. B) Quan-
tification of arbitrary fluorescence intensities in 20 B cells 
from 3 BLV- infected and 3 control sheep. Data are pre-
sented as the means of fluorescence intensities (± standard 
deviation). *** denotes the statistical significance according 
to the non paired Student's t test p < 0.001.
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Analysis of DNA oxidative damage Figure 3
Analysis of DNA oxidative damage. After 24 h of cul-
ture of PBMCs from BLV-infected (n = 3) and control (n = 3) 
sheep, cells were stained for IgM and 8-hydroxy-2'-deoxygua-
nosine (8-OHdG) and analyzed by flow cytometry. Data are 
presented as the percentages of 8-OHdG positive B cells (± 
standard deviation) in the total B cell population. *** denotes 
the statistical significance according to the non paired Stu-
dent's t test p < 0.001.
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Very little is known about the involvement of the ROS
pathway in BLV infection. To our knowledge, a single
report showed that the addition of low concentrations of
H2O2 (10-20  μM) increased BLV capsid protein (p24)
expression in BLV-infected cell lines [24]. Higher concen-
trations of H2O2 (200-300 μM) inhibited proliferation as
well as p24 expression, and induced apoptosis. Our
present study is the first that correlates spontaneous ex vivo
apoptosis, ROS production and proviral loads in BLV-
infected sheep.
As a preliminary remark, we should first emphasize that in
the absence of culture or after short culture intervals (<6
h), similar ROS levels are measured in BLV-infected and
control B cells (Additional file 2). Although it is possible
that viral replication and/or expression are prerequisites
for ROS inhibition ex vivo, a more likely interpretation is
that survival in vivo of both uninfected and BLV-infected B
lymphocytes requires adequate ROS levels to persist in the
sheep.
A second important point to address concerns the appar-
ent conflict between conclusions drawn from ex vivo and
in vivo observations. Why should BLV-infected cells (thus
less prone to undergo ex vivo apoptosis) have a shorter
lifespan in vivo [9,10]? The most straightforward interpre-
tation is that BLV-infected lymphocytes are indeed more
resistant to apoptosis in vivo but that these cells are effi-
ciently destroyed by the host immune response. Accord-
ing to this model, there is thus no contradiction between
inhibition of apoptosis ex vivo and increased cell turnover
in vivo. This interpretation is also compatible with the fact
that ROS levels correlate positively with apoptosis (Fig.
1C) and negatively with proviral loads (Fig. 6).
The balance between beneficial and deleterious effects of
ROS is believed to be critical for cell survival and is
achieved by a mechanism called "redox homeostasis"
[25]. As a defense against oxidative stress, cells possess
several antioxidant enzymes such as superoxide dis-
mutase, catalase, glutathione peroxidase and thioredoxin
(TRX) [18]. Altered expression of these proteins and dis-
ruption of ROS homeostasis has been involved in the
development of virus-induced malignancies [26]. Intrac-
ellular overexpression of TRX was detected in cells trans-
formed by oncoviruses including HTLV-1, Epstein-Barr
and Human Papilloma virus [27-29]. HTLV-1 trans-
formed T lymphocytes constitutively release high levels of
TRX that increase upon addition of H2O2;; this limits ROS
production and protects cells from apoptosis [30]. On the
other hand, deregulation of the TRX system associated
with low levels of glutathione has been largely implicated
in the physiopathology of HIV-1 [31-33]. In fact, the anti-
apoptotic function of glutathione inversely correlates with
the terminal lymphodepletion observed during the AIDS
phase. HTLV-1-infected cell survival depends on the bal-
anced effects of Tax, p13 and p12 regulatory proteins
(reviewed in [34]). Two of these proteins, Tax and p13,
have opposite effects on the redox state regulation.
Indeed, p13 increases ROS production via mitochondria
depolarization resulting in an increase of cell death [35].
Inversely, HTLV-1 Tax stimulates thioredoxin expression
which results in ROS decrease and subsequently growth of
transformed cells [36,37]. Our data demonstrate that B
cells isolated from BLV-infected sheep overexpress thiore-
doxin (Fig. 4B). However, our preliminary results indicate
that thioredoxin expression does not appear to be directly
controlled by BLV Tax protein (data not shown).
The development of strategies to modulate cell signaling
by restoring "redox homeostasis" may be a promising
anti-cancer therapy. Indeed, some compounds such as the
SAHA histone deacetylase inhibitor can target the thiore-
Analysis of thioredoxin expression Figure 4
Analysis of thioredoxin expression. A) Western blot 
analysis of thioredoxin (TRX) expression in PBMCs isolated 
from BLV-infected (n = 5) and control (n = 5) sheep using a 
goat polyclonal antibody specific for TRX. Actin was analyzed 
in parallel as a loading control. B) Immunofluorescence stain-
ing of thioredoxin was performed with 106 PBMCs/ml iso-
lated from BLV-infected (n = 8) and control (n = 5) sheep. 
After B cell staining using anti-IgM monoclonal antibody 
(clone Pig45) and Alexa Fluor 647-conjugated donkey anti-
mouse antibodies, cells were fixed in paraformaldehyde (4%) 
and permeabilised with PBS/TritonX-100 (0.5%). Cells were 
then incubated with anti-human TRX monoclonal antibody 
and Alexa Fluor 488 goat anti-mouse conjugate and analyzed 
by flow cytometry. Results are presented as the means of flu-
orescence intensities (± standard deviation) of TRX in B and 
non-B cells. ** denotes the statistical significance according to 
the non paired Student's t test p < 0.01.
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Figure 5
Effect of VPA on apoptosis and ROS production. PBMCs from BLV-infected and control sheep were isolated and culti-
vated for 24 h in the absence (0) or the presence of 1 mM of VPA. A) Representative Western blot analysis using an antibody
specific for the acetylated form of histone H3. Actin was analyzed in parallel as a loading control. B) The extent of B cell apop-
tosis was measured by determining the level of nuclear DNA fragmentation. B lymphocytes from 6 BLV-infected and control
sheep were labeled using an anti-IgM monoclonal antibody (clone 1H4) and a FITC-conjugated rabbit anti-mouse antiserum
(Becton Dickinson). After ethanol fixation and propidium iodide staining, hypodiploid B lymphocytes (i.e. in sub-G1) considered
to be apoptotic were quantified by flow cytometry. ** denotes the statistical significance of the differences between 0 and 1
mM VPA, accordingly to the paired Student's t test p < 0.01. C) ROS levels were evaluated in parallel after incubation of
PBMCs with 10 μM of CM-H2DCFDA probe prior to VPA treatment. Data represent the mean fluorescence intensities (±
standard deviation) of cellular chloromethyldichlorofluorescein (CM-DCF). * and ** denote the statistical significance of the dif-
ferences between 0 and 1 mM VPA, accordingly to the paired Student's t test (p < 0.05 and p < 0.01, respectively). D and E)
PBMCs from BLV-infected and control sheep were cultivated for 24 h in absence or presence of the free radical scavenger N-
acetyl-L-cysteine (NAC) added 2 h prior VPA treatment (1 mM). Cells isolated from BLV-infected and control sheep were ana-
lyzed by flow cytometry to determine the levels of intracellular ROS (D) and the rates of apoptosis (E). ** and *** denote the
statistical significances according to the paired Student's t test (p < 0.01 and p < 0.001, respectively).Retrovirology 2009, 6:102 http://www.retrovirology.com/content/6/1/102
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doxin system leading to ROS generation and induction of
apoptosis in cancer cells (for review, see [38]). HDAC
inhibitors are known to be proapoptotic for cells infected
by HTLV-1 [39], EBV [40] and HPV [41]. In a previous
report [21], we demonstrated that VPA induces apoptosis
of BLV-infected B cells and hypothesized that this effect
was mediated at least in part through HDAC inhibition.
We now show that VPA increases ROS production in BLV-
infected B cells providing a non exclusive alternative
mode of action. However, VPA treatment of PBMCs iso-
lated from BLV-infected and control sheep had no effect
on thioredoxin expression (data not shown), suggesting
that VPA acts through another antioxidant pathway.
Importantly, the free radical scavenger NAC concomi-
tantly abrogates ROS production and VPA-induced apop-
tosis indicating that the intracellular oxidative state
directly triggers sensitivity to VPA. In fact, HDAC inhibi-
tion and ROS stimulation may be linked through chroma-
tin relaxation and transcriptional activation of specific
cellular genes. In particular, VPA has been shown to acti-
vate redox-sensitive transcription factors (Nrf2) and their
subsequent interaction with the anti-oxidant response ele-
ment (ARE) on specific gene promoters [42].
In conclusion, we have demonstrated in this report that
direct inhibition of apoptosis by bovine leukemia virus
correlates with reduced production of reactive oxygen spe-
cies ex vivo, a mechanism that implicates the thioredoxin
system. Our results thus provide evidence linking inhibi-
tion of apoptosis and reduced ROS levels resulting in a
low DNA oxidative damage in BLV-infected B cells. These
data are consistent with a virus-associated ROS scavenging
mechanism conferring a reducing environment and inter-
fering with apoptosis of the infected cell. Finally, it is
noteworthy that resistance to oxidative stress ex vivo corre-
lates with increased proviral loads in vivo.
Methods
Experimental animals
A total of 13 BLV-infected sheep and 7 controls used in
this study were maintained under restricted conditions at
the Agricultural University of Gembloux (Belgium) and
the National Veterinary Research Institute of Pulawy
(Poland). Sheep # 4, 5, 6, 12, 13, 15, 16, 17, 18, 19, 4219,
5183 and 5193 were infected by a wild type proviral clone
of BLV strain 344 (pBLV344) [43]. All infected animals
were either in the asymptomatic stage of the disease (total
leukocyte counts ranging below 10,000 cells per mm3) or
lymphocytic (above 10,000 cells per mm3). Sheep # 5050,
5209, 7053, 7057, 9, B20 and M21 were used as unin-
fected controls.
Isolation of PBMCs and ex vivo culture
Peripheral blood mononuclear cells (PBMCs) were iso-
lated by density-gradient centrifugation using Percoll (GE
Healthcare). Briefly, venous blood was collected by jugular
venipuncture and mixed with EDTA used as an anticoagu-
lant (1 ml of 7.5% EDTA per 25 ml of blood). PBMCs
were washed twice with phosphate-buffered saline (PBS)
supplemented with 0.075% EDTA and three time with
PBS alone to deplete platelets. After estimation of cell via-
bility by trypan blue dye exclusion, 106 cells were seeded
in 24 well plates and cultivated for 24 h at 37°C in a
humidified, 5% CO2-air incubator in RPMI 1640 medium
(Lonza) supplemented with 10% of fetal calf serum (FCS),
2 mM L-glutamine, 100 U of penicillin and 100 μg of
streptomycin (Lonza). PBMCs isolated from non infected
sheep were used as controls. To determine the percentage
of B lymphocytes, PBMCs were labeled with anti-IgM
monoclonal antibody (clones 1H4 or Pig45) and with
FITC-conjugated rabbit anti-mouse (Dako) or Alexa Fluor
647-conjugated donkey anti-mouse antibodies (Invitro-
gen), respectively. Cells were then analyzed by flow
cytometry using a FacsAria apparatus (Becton Dickinson).
Detection of apoptosis
The B cell apoptotic rates were determined by evaluating
DNA fragmentation using propidium iodide (PI) staining.
Briefly, B cells were labeled using anti-IgM monoclonal
(clone 1H4) and FITC-conjugated rabbit anti-mouse (Bec-
ton Dickinson) antibodies, and fixed in 70% ethanol at -
20°C for at least 1 h. After two washes, cells were treated
with RNAse A (50 μg/ml) (Sigma/Aldrich) for 30 min at
37°C, centrifuged and resuspended in PBS containing 20
μg/ml propidium iodide (Sigma/Aldrich). The percentage
Correlation between ROS levels and proviral loads Figure 6
Correlation between ROS levels and proviral loads. 
Proviral loads (expressed as numbers of viral copies in B 
cells) were measured by real-time PCR in PBMCs isolated 
from BLV-infected sheep (n = 13). ROS levels were meas-
ured in B cells cultivated for 24 h using the CM-H2DCFDA 
probe. A correlation coefficient R2 = 0.7764 was calculated. p 
< 0.001 was determined using the non parametric Spearman 
test.
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of B-cells undergoing nuclear DNA fragmentation was
then quantified using a FacsAria flow cytometer (Becton
Dickinson). Cell aggregates were excluded from the analy-
sis using the FSC-A/FSC-H gating method. Ten thousand
events were collected and analyzed with the FacsDiva soft-
ware. Data are given in percentages of hypodiploid B-cells
staining at sub-G1 fluorescence intensity and reflecting
the number of B-apoptotic cells. To determine the effect of
VPA on apoptosis, PBMCs (1.106) isolated from BLV-
infected and control sheep were cultivated in the absence
and the presence of 1 mM VPA (Sigma/Aldrich) and the
percentages of apoptotic B cells were determined as
described above.
Analysis of reactive oxygen species (ROS) production
Intracellular ROS levels were monitored using 5,6-chlo-
romethyl-2',7'-dichlorodihydrofluorescein diacetate
acetyl ester (CM-H2DCFDA, Invitrogen), a probe which is
oxidized to 2'-7'-dichlorofluorescein upon ROS stimula-
tion. PBMCs from BLV-infected and control sheep were
seeded in 24-wells plates at a density of 106cells/ml and
incubated for 30 min at 37°C with 10 μM of CM-
H2DCFDA. After 24 h of culture, B cells were stained using
anti-IgM monoclonal (clone Pig45) and Alexa Fluor 647-
conjugated donkey anti-mouse antibodies (Invitrogen).
Cells were then collected, washed with PBS and analyzed
with a FacsAria flow cytometer. The fluorescence intensity
of chloromethyldichlorofluorescein (CM-DCF) was
detected at a wavelength of 530 nm after a laser excitation
beam of 480 nm. B cell specific staining was measured at
a wavelength of 650 nm after excitation with a 630 nm
laser beam. To determine the effect of VPA on ROS pro-
duction, PBMCs from BLV-infected and control sheep
were preincubated for 30 min at 37°C with 10 μM CM-
H2DCFDA and then cultivated with VPA (1 mM). For ROS
inhibition experiments, cells were treated with 10 mM of
the free radical scavenger N-acetyl-L-cysteine (NAC) (Cal-
biochem) 2 h prior to incubation with the CM-H2DCFDA
probe.
Measurement of ROS production in B cell mitochodria
Production of ROS in mitochondria was measured using
MitoTracker Red CM-XROS (Molecular probes), a derivative
of X-rosamines that accumulates in mitochondria and
produces a red fluorescent signal upon oxidation with
H2O2. PBMCs from BLV-infected and control sheep were
cultivated in 24-well plates containing poly lysine-coated
12-mm glass coverslips. 24 h later, cells were incubated
for 45 min with 10 nM of Red CM-XROS probe, washed
and fixed in paraformaldehyde/PBS 4/100 (v/v). B cells
were stained using anti-IgM monoclonal (clone Pig45)
and Alexa Fluor 488-conjugated goat anti-mouse antibod-
ies (Invitrogen). After mounting coverslips in Tris Buff-
ered Saline (TBS)/Glycerol, cells were analyzed by
confocal fluorescence microscopy (Axiovert 200 micro-
scope with a LSM 510 confocal device; Carl Zeiss Micro-
scope) using argon (488 nm) and HeNe (633 nm) lasers.
Measurement of DNA oxidative damage in B cells
The extent of DNA damage resulting from oxidative stress
was evaluated by quantification of the major oxidative
DNA product: 8-hydroxy-2'-deoxyguanosine (8-OHdG),
using the OxyDNA assay Kit (Calbiochem) according to the
manufacturer's instructions. Briefly, PBMCs from BLV-
infected and control sheep were cultivated for 24 h at a
density of 106 cells/ml. After staining of B cells using anti-
IgM monoclonal (clone Pig45) and Alexa Fluor 647-con-
jugated donkey anti-mouse antibodies (Invitrogen), cells
were fixed in paraformaldehyde/PBS 4/100 (v/v) and per-
meabilised with PBS/TritonX-100 5/1000 (v/v). After a
final wash, cells were labeled for 1 h with an 8-oxogua-
nine specific FITC-conjugate and analyzed by flow cytom-
etry using a FacsAria apparatus.
Flow cytometry analysis of thioredoxin
After B cell staining using anti-IgM monoclonal (clone
Pig45) and Alexa Fluor 647-conjugated donkey anti-
mouse antibodies (Invitrogen), cells were fixed in parafor-
maldehyde/PBS 4/100 (v/v), permeabilised with PBS/Tri-
tonX-100 5/1000 (v/v) and labeled with an anti-human
TRX monoclonal antibody (BD Pharmingen) and with
Alexa Fluor 488-conjugated goat anti-mouse antibodies
(Invitrogen). Mean fluorescence intensities of thioredoxin
levels were measured by flow cytometry using a FacsAria
apparatus.
Western immunoblotting of acetylated histone H3 and 
thioredoxin expression
PBMCs from BLV-infected and control sheep were culti-
vated for 24 h in the absence or the presence of 1 mM of
VPA. Cells (5 × 106) were harvested by centrifugation at
500 g for 10 min at 4°C and washed with ice-cold PBS,
then lysed by incubation for 30 min on ice in RIPA buffer
(50 mM Tris pH 7.5, 150 mM NaCl, 0.1% SDS, 1% NP-
40, 0.5% sodium deoxycholate, supplemented with Com-
plete  protease inhibitors, Roche). After centrifugation at
13,000 g for 10 min, the supernatant was stored at -80°C.
Proteins were quantified using Micro-BCA protein assay
kit (Pierce) and 20 μg were electrophoresed on a 15% SDS-
polyacrylamide gel and blotted onto a nitrocellulose
membrane (GE Health). Filters were incubated overnight
at 4°C in presence of anti-acetylated histone H3 (Upstate
Cell Signaling), anti-TRX (Santa Cruz Biotechnology) or anti-
actin (Sigma/Aldrich) antibodies followed by subsequent
treatment with horseradish peroxidase conjugates (Santa
Cruz Biotechnology) for 1 h at room temperature. Immuno-
reactive bands were visualized using the ECL Advance
western blot detection reagent (GE Health).Retrovirology 2009, 6:102 http://www.retrovirology.com/content/6/1/102
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Determination of proviral load
Genomic DNA was extracted from PBMCs of BLV-infected
sheep using the DNeasy Kit (Quiagen) according to the
manufacturer's instructions. One hundred nanograms of
genomic DNA were used for real-time PCR amplification
of BLV proviral sequences. A segment corresponding to
the pol  gene (nucleotide 3994 to 4060) was amplified
with a final concentration of 900 nM of 2 primers: (5'-
GAAACTCCAGAGCAATGGCATAA-3' and 5'-GGTTCG-
GCCATCGAGACA-3') and revealed with a Minor Groove
Binder (MGB) fluorescent probe (250 nM of 6-carboxyflu-
orescein-CTCACCCACTGCAAC-MGB) using the TaqMan
PCR universal master mix with a StepOne apparatus
(Applied Biosystems). A standard curve was generated after
amplification of defined copy numbers (from 1 to 107 of
plasmid pBLV344) with 100 ng of control genomic DNA.
To correct for differences in DNA concentrations and
amplification efficiencies between samples, the 18S ribos-
omal DNA was amplified in parallel using a final concen-
tration of 900 nM of the following pair of primers: (5-
TTGGATAACTGTGGTAATTCTAGAAGCTAA-3' and 5'-
CGGGTTGGTTTTGATCTGATAAAT-3') and 250 nM of the
6-carboxyfluorescein-CATGCCGACGGGCGCTGA-MGB
probe. The proviral loads were finally normalized to the
percentage of B lymphocytes.
Statistical analysis
Statistical significances of experimental data were ana-
lyzed using the Student's t test and the non parametric
Spearman test. The observed differences between experi-
mental results were stated as statistically significant,
highly statistically significant and very highly statistically
significant when p < 0.05 (*), p < 0.01 (**) and p < 0.001
(***), respectively.
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